Search

Your search keyword '"Rui-hua Xu"' showing total 834 results

Search Constraints

Start Over You searched for: Author "Rui-hua Xu" Remove constraint Author: "Rui-hua Xu"
834 results on '"Rui-hua Xu"'

Search Results

1. YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity

2. A phase II clinical trial of toripalimab in advanced solid tumors with polymerase epsilon/polymerase delta (POLE/POLD1) mutation

3. Machine learning-based extrachromosomal DNA identification in large-scale cohorts reveals its clinical implications in cancer

4. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023

5. Development of antibody‐drug conjugates in cancer: Overview and prospects

6. Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer

7. Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.

8. The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer

9. MFSD2A potentiates gastric cancer response to anti‐PD‐1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response

10. Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response

11. Latent class analysis-derived classification improves the cancer-specific death stratification of molecular subtyping in colorectal cancer

12. A pilot study of lymphodepletion intensity for peripheral blood mononuclear cell-derived neoantigen-specific CD8 + T cell therapy in patients with advanced solid tumors

13. Clinical and molecular characteristics of mutations as promising prognostic biomarkers in colorectal cancer

15. Gastric cancer treatment: recent progress and future perspectives

16. Long noncoding RNA Regulating ImMune Escape regulates mixed lineage leukaemia protein‐1‐H3K4me3‐mediated immune escape in oesophageal squamous cell carcinoma

18. First-in-human phase Ia study of the PI3Kα inhibitor CYH33 in patients with solid tumors

19. Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systemic therapy of gastric cancer

20. Precise microdissection of gastric mixed adeno-neuroendocrine carcinoma dissects its genomic landscape and evolutionary clonal origins

21. Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

22. Comprehensive profiling of 1015 patients’ exomes reveals genomic-clinical associations in colorectal cancer

23. Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis

24. Long-term effect of hospital volume on the postoperative prognosis of 158,618 patients with esophageal squamous cell carcinoma in China

25. The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p

26. Focal amplifications are associated with chromothripsis events and diverse prognoses in gastric cardia adenocarcinoma

27. Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine

28. Advancing to the era of cancer immunotherapy

29. A novel computational framework for integrating multidimensional data to enhance accuracy in predicting the prognosis of colorectal cancer

31. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

32. DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in gastric cancer

33. Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer

34. The lncRNA XIST/miR‐125b‐2‐3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer

35. Temporal Change in Treatment Patterns of Metastatic Colorectal Cancer and Its Association with Patient Survival: A Retrospective Cohort Study Based on an Intelligent Big-Data Platform

36. A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy

37. LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer

38. PD-L1 expression in liver metastasis: its clinical significance and discordance with primary tumor in colorectal cancer

39. Circular RNA: metabolism, functions and interactions with proteins

40. Germline mutational profile of Chinese patients under 70 years old with colorectal cancer

41. The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors

43. A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumors

44. Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming

45. Classification of gastric cancer by EBV status combined with molecular profiling predicts patient prognosis

46. CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17

47. Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer

49. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer

50. Correction to: CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17

Catalog

Books, media, physical & digital resources